{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:19:06Z","timestamp":1787951946772,"version":"build-2784847793"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijgc.2025.102750","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:02:46Z","timestamp":1761116566000},"page":"102750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adjuvant, neoadjuvant, and surgical treatment for locally advanced cervical cancer: a Bayesian network meta-analysis"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7154-8692","authenticated-orcid":false,"given":"Isadora","family":"Mamede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2668-3945","authenticated-orcid":false,"given":"Israt Jahan","family":"Riya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1577-7056","authenticated-orcid":false,"given":"Ifrat Jahan","family":"Piya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8617-966X","authenticated-orcid":false,"given":"Rafael Lara","family":"Nohmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Gazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devanie","family":"Martani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davi Santos","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9103-9119","authenticated-orcid":false,"given":"Carlos","family":"Stecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2025.102750_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib3","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"10.1016\/j.ijgc.2025.102750_bib4","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.3390\/jcm13154458","article-title":"New frontiers in locally advanced cervical cancer treatment","volume":"13","author":"Massobrio","year":"2024","journal-title":"J Clin Med"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2025.102750_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102750_bib6","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e82","article-title":"A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial","volume":"30","author":"Tangjitgamol","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib7","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e10","article-title":"Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor","volume":"35","author":"Li","year":"2024","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102750_bib8","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.31557\/APJCP.2021.22.9.2977","article-title":"Long-term outcomes and sites of failure in locally advanced, cervical cancer patients treated by concurrent chemoradiation with or without adjuvant chemotherapy: ACTLACC trial","volume":"22","author":"Tovanabutra","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102750_bib9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(23)00147-X","article-title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial","volume":"24","author":"Mileshkin","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10462","key":"10.1016\/j.ijgc.2025.102750_bib10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","article-title":"Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial","volume":"404","author":"McCormack","year":"2024","journal-title":"Lancet"},{"issue":"10434","key":"10.1016\/j.ijgc.2025.102750_bib11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102750_bib12","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1470-2045(23)00479-5","article-title":"Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial","volume":"24","author":"Monk","year":"2023","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib13","first-page":"757","article-title":"Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil\/lymphocyte ratio of stage IB2-IIB cervical cancer","volume":"25","author":"Wang","year":"2020","journal-title":"J BUON"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102750_bib14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0959-8049(00)00034-4","article-title":"The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer","volume":"36","author":"Symonds","year":"2000","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1634\/theoncologist.2011-0276","article-title":"Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer","volume":"17","author":"Morice","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijgc.2025.102750_bib17","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2025.102750_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074495","article-title":"A guide and pragmatic considerations for applying GRADE to network meta-analysis","volume":"381","author":"Izcovich","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2025.102750_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.22159\/ajpcr.2022.v15i7.44947","article-title":"Treatment outcome and toxicity of neoadjuvant chemotherapy followed by concomitant chemoradiotherapy versus concomitant chemoradiation alone in locally advanced cervical carcinoma: a comparative study","author":"Banerjee","year":"2022","journal-title":"Asian J Pharm Clin Res"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2002.20.1.179","article-title":"Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study","volume":"20","author":"Benedetti-Panici","year":"2002","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102750_bib21","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/annonc\/mdt142","article-title":"Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients","volume":"24","author":"Cetina","year":"2013","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102750_bib22","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/JCO.2000.18.8.1740","article-title":"Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer","volume":"18","author":"Chang","year":"2000","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1016\/j.ijgc.2025.102750_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ygyno.2008.05.026","article-title":"Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study","volume":"110","author":"Chen","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"33","key":"10.1016\/j.ijgc.2025.102750_bib24","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1200\/JCO.19.00674","article-title":"Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: A randomized Phase II trial","volume":"37","author":"da Costa","year":"2019","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ijgc.2025.102750_bib25","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2007.04.007","article-title":"Treatment of (\u201cbulky\u201d) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic\/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group","volume":"106","author":"Eddy","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102750_bib27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90\u201301","volume":"22","author":"Eifel","year":"2004","journal-title":"J Clin Oncol"},{"issue":"919","key":"10.1016\/j.ijgc.2025.102750_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1259\/bjr\/63967203","article-title":"Adding concurrent low dose continuous infusion of cisplatin to radiotherapy in locally advanced cervical carcinoma: a prospective randomized pilot study","volume":"77","author":"Garipa\u011fao\u011flu","year":"2004","journal-title":"Br J Radiol"},{"issue":"16","key":"10.1016\/j.ijgc.2025.102750_bib29","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102750_bib30","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1023\/A:1008346901733","article-title":"A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix","volume":"11","author":"Herod","year":"2000","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12957-021-02318-y","article-title":"Neoadjuvant chemotherapy combined with radical surgery for stage IB2\/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients","volume":"19","author":"Jing","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102750_bib32","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/bjc.2013.179","article-title":"Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)","volume":"108","author":"Katsumata","year":"2013","journal-title":"Br J Cancer"},{"issue":"32","key":"10.1016\/j.ijgc.2025.102750_bib33","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1200\/JCO.22.02852","article-title":"Randomized Phase III study comparing neoadjuvant chemotherapy followed by surgery versus chemoradiation in stage IB2-IIB cervical cancer: EORTC-55994","volume":"41","author":"Kenter","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102750_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0090-8258(03)00173-2","article-title":"Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group","volume":"89","author":"Keys","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102750_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/gyno.1994.1215","article-title":"Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study","volume":"54","author":"Kumar","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102750_bib36","article-title":"Accelerated radiotherapy alone versus chemoradiation in locally advanced carcinoma cervix: long-term outcomes","volume":"16","author":"Kushwaha","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102750_bib37","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.3802\/jgo.2017.28.e34","article-title":"Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update","volume":"28","author":"Landoni","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"9077","key":"10.1016\/j.ijgc.2025.102750_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0360-3016(96)00491-9","article-title":"Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial. International Journal of Radiation Oncology\u2217Biology\u2217Physics","volume":"37","author":"Leborgne","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1748-717X-9-212","article-title":"A comparison of concurrent chemoradiotherapy and radiotherapy in Chinese patients with locally advanced cervical carcinoma: a multi-center study","volume":"9","author":"Li","year":"2014","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib41","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e10","article-title":"Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor","volume":"35","author":"Li","year":"2024","journal-title":"J Gynecol Oncol"},{"issue":"10434","key":"10.1016\/j.ijgc.2025.102750_bib42","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"10460","key":"10.1016\/j.ijgc.2025.102750_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102750_bib44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0360-3016(02)04405-X","article-title":"Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial","volume":"55","author":"Lorvidhaya","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10462","key":"10.1016\/j.ijgc.2025.102750_bib45","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","article-title":"Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial","volume":"404","author":"McCormack","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102750_bib46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(23)00147-X","article-title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial","volume":"24","author":"Mileshkin","year":"2023","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102750_bib47","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1470-2045(23)00479-5","article-title":"Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial","volume":"24","author":"Monk","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1634\/theoncologist.2011-0276","article-title":"Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer","volume":"17","author":"Morice","year":"2012","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102750_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00066-009-1893-z","article-title":"Radiotherapy versus Concurrent 5-day cisplatin and Radiotherapy in Locally Advanced Cervical Carcinoma. Long-term results of a phase III randomized trial","volume":"185","author":"Nagy","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102750_bib50","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1200\/JCO.2002.20.4.966","article-title":"Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix","volume":"20","author":"Pearcey","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102750_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1525-1438.1998.09862.x","article-title":"Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial","volume":"8","author":"Sardi","year":"1998","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2025.102750_bib52","unstructured":"Sehgal CM, Patel FD, Ghoshal S, Kehwar TS, Sharma RR. Kapoor\u2019 R. Comparative Evaluation of Concurrent Chemotherapy & Hyperfractionated Radiotherapy Versus Conventional Radiotherapy Alone in the Treatment of Locally Advanced Carcinoma Cervix-A Prospective Randomised Study."},{"issue":"1","key":"10.1016\/j.ijgc.2025.102750_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0973-1482.148676","article-title":"Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: results of a prospective randomized phase III trial","volume":"12","author":"Sharma","year":"2016","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102750_bib54","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","article-title":"Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: A randomized clinical trial","volume":"4","author":"Shrivastava","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102750_bib55","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1200\/JCO.1991.9.6.970","article-title":"A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix","volume":"9","author":"Souhami","year":"1991","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102750_bib56","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ajog.2007.08.003","article-title":"Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial","volume":"197","author":"Stehman","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102750_bib57","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0959-8049(00)00034-4","article-title":"The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer","volume":"36","author":"Symonds","year":"2000","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102750_bib58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1525-1438.1992.02050244.x","article-title":"A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer","volume":"2","author":"Tattersall","year":"1992","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1200\/JCO.1995.13.2.444","article-title":"Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association","volume":"13","author":"Tattersall","year":"1995","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102750_bib60","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.31557\/APJCP.2021.22.9.2977","article-title":"Long-term outcomes and sites of failure in locally advanced, cervical cancer patients treated by concurrent chemoradiation with or without adjuvant chemotherapy: ACTLACC trial","volume":"22","author":"Tovanabutra","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102750_bib61","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e82","article-title":"A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial","volume":"30","author":"Tangjitgamol","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib62","first-page":"757","article-title":"Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil\/lymphocyte ratio of stage IB2-IIB cervical cancer","volume":"25","author":"Wang","year":"2020","journal-title":"J BUON"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IGC.0b013e31823610a1","article-title":"A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer","volume":"22","author":"Wen","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102750_bib64","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.1999.17.7.2055","article-title":"Chemoradiation and adjuvant chemotherapy in cervical cancer","volume":"17","author":"Wong","year":"1999","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/gyn.2009.0039","article-title":"A randomized trial of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy alone in Stage IIIb carcinoma of the uterine cervix","volume":"26","author":"Yamauchi","year":"2010","journal-title":"J Gynecol Surg"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib66","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.ijrobp.2024.07.203","article-title":"Induction Chemotherapy plus Concurrent chemoradiotherapy vs. concurrent chemoradiotherapy Alone in High-Risk Locally Advanced Cervical Carcinoma: A Phase 2, Multicenter, randomized controlled trial","volume":"120","author":"Yang","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2015.06.027","article-title":"The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: a randomized multicenter study","volume":"141","author":"Yang","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102750_bib68","first-page":"942","article-title":"[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma]","volume":"27","author":"Zeng","year":"2008","journal-title":"Ai Zheng"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102750_bib69","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","article-title":"NCCN Guidelines\u00ae Insights: Cervical Cancer, Version 1.2024","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijgc.2025.102750_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221086403","article-title":"Treatment strategies and prognostic factors of 2018 FIGO stage IIIC cervical cancer: a review","volume":"21","author":"Qin","year":"2022","journal-title":"Technol Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102750_bib71","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.1921445117","article-title":"Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy","volume":"117","author":"Wang","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10460","key":"10.1016\/j.ijgc.2025.102750_bib72","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijgc.2025.102750_bib73","article-title":"Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102750_bib75","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0033","article-title":"Cost-effectiveness of pembrolizumab with chemoradiotherapy for locally advanced cervical cancer","volume":"8","author":"Courtney","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102750_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jrr\/rrae073","article-title":"Clinical efficacy and safety of neoadjuvant chemotherapy with paclitaxel and cisplatin in combination with concurrent chemoradiotherapy for locally advanced cervical cancer: a systematic review and meta-analysis","volume":"65","author":"Yeshe","year":"2024","journal-title":"J Radiat Res"},{"issue":"33","key":"10.1016\/j.ijgc.2025.102750_bib77","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1200\/JCO.19.00674","article-title":"Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase II trial","volume":"37","author":"da Costa","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102750_bib78","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.ijrobp.2024.07.203","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy vs. concurrent chemoradiotherapy alone in high-risk locally advanced cervical carcinoma: a phase 2, multicenter, randomized controlled trial","volume":"120","author":"Yang","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102750_bib79","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/annonc\/mdg333","article-title":"A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation","volume":"14","author":"Due\u00f1as-Gonzalez","year":"2003","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.ijgc.2025.102750_bib80","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijgc.2025.102750_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.745522","article-title":"Neoadjuvant and adjuvant treatments compared to concurrent chemoradiotherapy for patients with locally advanced cervical cancer: a Bayesian network meta-analysis","volume":"12","author":"Qiao","year":"2022","journal-title":"Front Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25018705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25018705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:38:08Z","timestamp":1787949488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25018705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1048891X25018705"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102750","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant, neoadjuvant, and surgical treatment for locally advanced cervical cancer: a Bayesian network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102750"}}